LIPIXELLE

Serial Number 88440528
Registration 6077874
700

Registration Progress

Application Filed
May 21, 2019
Under Examination
Approved for Publication
Mar 31, 2020
Published for Opposition
Mar 31, 2020
Registered
Jun 16, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-16)
Due: Jun 16, 2026 337 days

Trademark Image

LIPIXELLE

Basic Information

Serial Number
88440528
Registration Number
6077874
Filing Date
May 21, 2019
Registration Date
June 16, 2020
Published for Opposition
March 31, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 16, 2020
Registration
Registered
Classes
005

Rights Holder

Sun Pharma Advanced Research Company Limited

16
Address
17-B, Mahal Industrial Estate,
Mahakali Caves Road, Andheri (East)
Mumbai 400063
IN

Ownership History

Sun Pharma Advanced Research Company Limited

Original Applicant
16
Mumbai IN

Sun Pharma Advanced Research Company Limited

Owner at Publication
16
Mumbai IN

Sun Pharma Advanced Research Company Limited

Original Registrant
16
Mumbai IN

Legal Representation

Attorney
Craig Kuchii, Esq.

USPTO Deadlines

Next Deadline
337 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-16)
Due Date
June 16, 2026
Grace Period Ends
December 16, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

20 events
Date Code Type Description
Jun 16, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 16, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER
Mar 31, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2020 PUBO A PUBLISHED FOR OPPOSITION
Mar 11, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 25, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED
Feb 25, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 25, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED
Feb 25, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 25, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN
Feb 19, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 19, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 18, 2020 ALIE A ASSIGNED TO LIE
Feb 11, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 13, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 13, 2019 GNRT F NON-FINAL ACTION E-MAILED
Aug 13, 2019 CNRT R NON-FINAL ACTION WRITTEN
Aug 7, 2019 DOCK D ASSIGNED TO EXAMINER
Jun 6, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Additional Information

Translation
The wording "LIPIXELLE" has no meaning in a foreign language.

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...